Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Objective: To conduct a retrospective comparative analysis of endoscopic-assisted burr hole craniostomy (EBHC) vs. two burr hole craniostomy (TBHC) in the management of septated chronic subdural hematoma (sCSDH).
Methods: This study employed a retrospective cohort design, encompassing 87 patients diagnosed with sCSDH who were admitted for EBHC or TBHC between January 2018 and December 2023. Among these patients, 48 underwent EBHC, while 39 received TBHC. The primary outcome measure was the recurrence rate within 6 months following surgery. Secondary outcomes included clinical outcomes at discharge and 6 months, duration of hospitalization, and duration of drainage tube placement.
Results: The recurrence rates were comparable between EBHC and TBHC groups (12.5% vs. 10.3%, = 0.742). However, the mean operative time was significantly longer for the EBHC group, averaging 103.56 ± 20.93 min, in contrast to the TBHC group, which averaged 50.77 ± 12.40 min ( < 0.001). Additionally, the mean placement time for the drainage tube was significantly shorter in the EBHC group (18.66 ± 5.89 h) compared to the TBHC group (55.87 ± 23.03 h, < 0.001). Furthermore, the mean length of hospital stay was notably reduced for the EBHC group (6.02 ± 1.68 days) compared to the TBHC group (4.66 ± 1.79 days, < 0.001). There were no significant differences in mortality rates, complication rates, MRS scores, GCS scores, or the presence of gross focal neurological deficits postoperatively between the groups.
Conclusion: TBHC is an effective intervention for sCSDH, offering a less invasive alternative with shorter operative duration and comparable recurrence rates to EBHC. Nonetheless, the efficacy of this approach requires further validation through large, multicenter studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11996650 | PMC |
http://dx.doi.org/10.3389/fneur.2025.1540877 | DOI Listing |